Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01300 |
| Species: | Homo sapiens |
| Position : | chr6:135323137-135323537 |
| Year: | 2019 |
| Title: | Global Analysis of Enhancer Targets Reveals Convergent Enhancer-Driven Regulatory Modules |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | chronic myeloid leukemia |
| PMID: | 31775028 |
| MONDO: | MONDO:0011998 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | K562 |
| CVCL ID: | CVCL_0004 |
| Cell Type: | chronic myeloid leukemia cell |
| Cell Ontology ID: | CL:0001054 |
| Experiment Type: | Enhancer activity assay, Functional perturbation assay, Chromatin interaction assay |
| High Throughput Method: | scRNA-seq, RNA-seq, Hi-C, ChIP-seq, ATAC-seq |
| Low Throughput Method: | CRISPRi, RT-RT-qPCR |
| Target gene : | MYB |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01828 | chr6:135323327-135323580 | Liver | hepatocellular carcinoma cell | hepatocellular carcinoma |